Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1975 1
1977 2
1978 3
1979 2
1982 1
1983 2
1985 2
1986 2
1987 1
1988 4
1989 3
1990 7
1991 7
1992 10
1993 9
1994 28
1995 16
1996 19
1997 17
1998 19
1999 29
2000 21
2001 22
2002 20
2003 25
2004 37
2005 23
2006 41
2007 39
2008 42
2009 21
2010 28
2011 28
2012 25
2013 24
2014 29
2015 34
2016 40
2017 34
2018 25
2019 26
2020 27
2021 19
2022 27
2023 16

Text availability

Article attribute

Article type

Publication date

Search Results

800 results

Results by year

Filters applied: . Clear all
Page 1
Breast cancer in adolescents and young adults.
Johnson RH, Anders CK, Litton JK, Ruddy KJ, Bleyer A. Johnson RH, et al. Pediatr Blood Cancer. 2018 Dec;65(12):e27397. doi: 10.1002/pbc.27397. Epub 2018 Aug 28. Pediatr Blood Cancer. 2018. PMID: 30156052 Free PMC article. Review.
Breast cancer is the most common cancer of adolescents and young adult (AYA) women aged 15 to 39 years, accounting for 5.6% of all invasive breast cancer in women. In comparison with older women, AYAs are more likely to have familial c …
Breast cancer is the most common cancer of adolescents and young adult (AYA) women aged 15 to 39 years, accounting for …
Breast cancer genes: beyond BRCA1 and BRCA2.
Filippini SE, Vega A. Filippini SE, et al. Front Biosci (Landmark Ed). 2013 Jun 1;18(4):1358-72. doi: 10.2741/4185. Front Biosci (Landmark Ed). 2013. PMID: 23747889 Free article. Review.
Breast cancer (BC) is a heterogeneous disease. The majority of breast cancer cases (about 70 percent) are considered sporadic. ...Due to the development of next generation sequencing technologies, it is envisaged that all familial breast …
Breast cancer (BC) is a heterogeneous disease. The majority of breast cancer cases (about 70 percent) are consid …
Cancer genetics and breast cancer.
Huber-Keener KJ. Huber-Keener KJ. Best Pract Res Clin Obstet Gynaecol. 2022 Jun;82:3-11. doi: 10.1016/j.bpobgyn.2022.01.007. Epub 2022 Jan 31. Best Pract Res Clin Obstet Gynaecol. 2022. PMID: 35272929 Review.
The risk of developing breast cancer is multifactorial and, at times, modifiable. However, the risk imposed by family history and hereditary pathogenic variants in a person's genetic code is, at present, an important fixed variable. ...This chapter focuses on …
The risk of developing breast cancer is multifactorial and, at times, modifiable. However, the risk imposed by family history …
Molecular Testing in Breast Cancer.
Litton JK, Burstein HJ, Turner NC. Litton JK, et al. Am Soc Clin Oncol Educ Book. 2019 Jan;39:e1-e7. doi: 10.1200/EDBK_237715. Epub 2019 May 17. Am Soc Clin Oncol Educ Book. 2019. PMID: 31099622 Free article. Review.
Molecular testing for genetic and genomic variation has become an integral part of breast cancer management. Patients with a family history of breast cancer or other tumors, bilateral breast cancers, or early-onset breast cancers warrant …
Molecular testing for genetic and genomic variation has become an integral part of breast cancer management. Patients with a f …
Whole genome sequencing of breast cancer.
Rossing M, Sørensen CS, Ejlertsen B, Nielsen FC. Rossing M, et al. APMIS. 2019 May;127(5):303-315. doi: 10.1111/apm.12920. Epub 2019 Jan 28. APMIS. 2019. PMID: 30689231 Free PMC article. Review.
Breast cancer was the first to take advantage of targeted therapy using endocrine therapy, and for up to 20% of all breast cancer patients a further significant improvement has been obtained by HER2-targeted therapy. ...Large-scale sequencing data unra …
Breast cancer was the first to take advantage of targeted therapy using endocrine therapy, and for up to 20% of all breast …
Overview of hereditary breast and ovarian cancer (HBOC) guidelines across Europe.
Marmolejo DH, Wong MYZ, Bajalica-Lagercrantz S, Tischkowitz M, Balmaña J; extended ERN-GENTURIS Thematic Group 3. Marmolejo DH, et al. Eur J Med Genet. 2021 Dec;64(12):104350. doi: 10.1016/j.ejmg.2021.104350. Epub 2021 Oct 1. Eur J Med Genet. 2021. PMID: 34606975 Review.
Hereditary breast and ovarian cancer (HBOC) is a syndrome defined by an increased risk of developing breast and/or ovarian cancer most commonly due to germline disease-causing variants in the BRCA1 and BRCA2 genes, but also other causative genes such a …
Hereditary breast and ovarian cancer (HBOC) is a syndrome defined by an increased risk of developing breast and/or ovar …
Familial and hereditary gastric cancer, an overview.
Carneiro F. Carneiro F. Best Pract Res Clin Gastroenterol. 2022 Jun-Aug;58-59:101800. doi: 10.1016/j.bpg.2022.101800. Epub 2022 May 4. Best Pract Res Clin Gastroenterol. 2022. PMID: 35988963 Review.
There are three major hereditable syndromes that affect primarily the stomach: hereditary diffuse gastric cancer (HDGC), gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS) and familial intestinal gastric cancer (FIGC). ...GAPPS is caused by …
There are three major hereditable syndromes that affect primarily the stomach: hereditary diffuse gastric cancer (HDGC), gastric aden …
Breast cancer screening in young women.
Desreux JAC. Desreux JAC. Eur J Obstet Gynecol Reprod Biol. 2018 Nov;230:208-211. doi: 10.1016/j.ejogrb.2018.05.018. Epub 2018 May 24. Eur J Obstet Gynecol Reprod Biol. 2018. PMID: 29804884 Review.
Breast cancer is the leading cause of death by cancer in women aged less than 40. ...Individualized screening, targeting only some young high-risk women, may be beneficial although no randomized trial has proven an impact on breast cancer mortal …
Breast cancer is the leading cause of death by cancer in women aged less than 40. ...Individualized screening, targetin …
Skin diseases of the breast and nipple: Benign and malignant tumors.
Waldman RA, Finch J, Grant-Kels JM, Stevenson C, Whitaker-Worth D. Waldman RA, et al. J Am Acad Dermatol. 2019 Jun;80(6):1467-1481. doi: 10.1016/j.jaad.2018.08.066. Epub 2018 Nov 16. J Am Acad Dermatol. 2019. PMID: 30452954 Review.
An emphasis is placed on inflammatory breast cancer and breast cancer with noninflammatory skin involvement and on cutaneous metastases to the breast and from breast cancer. Familiarity of the dermatologist with the cutaneous manif …
An emphasis is placed on inflammatory breast cancer and breast cancer with noninflammatory skin involvement and …
Genetic Epidemiology of Breast Cancer in Latin America.
Zavala VA, Serrano-Gomez SJ, Dutil J, Fejerman L. Zavala VA, et al. Genes (Basel). 2019 Feb 18;10(2):153. doi: 10.3390/genes10020153. Genes (Basel). 2019. PMID: 30781715 Free PMC article. Review.
The last 10 years witnessed an acceleration of our understanding of what genetic factors underpin the risk of breast cancer. Rare high- and moderate-penetrance variants such as those in the BRCA genes account for a small proportion of the familial risk of …
The last 10 years witnessed an acceleration of our understanding of what genetic factors underpin the risk of breast cancer. R …
800 results